{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:41:24Z","timestamp":1778902884945,"version":"3.51.4"},"reference-count":15,"publisher":"Societas Neurologica Japonica","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.446","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T23:17:49Z","timestamp":1371683869000},"page":"446-451","source":"Crossref","is-referenced-by-count":15,"title":["A case of MELAS with G13513A mutation presenting with chronic kidney disease long before stroke-like episodes"],"prefix":"10.5692","volume":"53","author":[{"given":"Atsuko","family":"Motoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kurashige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemori","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.","DOI":"10.1038\/348651a0"},{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shanske S, Coku J, Lu J, et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or leigh syndrome. Arch Neurol 2008;65:368-372.","DOI":"10.1001\/archneurol.2007.67"},{"key":"4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lederer SR, Klopstock T, Schiffl H. MELAS: a mitochondrial disorder in an adult patient with a renal transplant. Wien Klin Wochenschr 2010;122:363-365.","DOI":"10.1007\/s00508-010-1388-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kurogouchi F, Oguchi T, Mawatari E, et al. A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol 1998;18:551-556.","DOI":"10.1159\/000013406"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kobayashi A, Goto Y, Nagata M, et al. Granular swollen epithelial cells: a histologic and diagnostic marker for mito chondrial nephropathy. Am J Surg Pathol 2010;34:262-270.","DOI":"10.1097\/PAS.0b013e3181cb4ed3"},{"key":"8"},{"key":"9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and stroke like episodes basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133-158.","DOI":"10.1196\/annals.1444.011"},{"key":"11"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Suzuki K, Honda K, Tanabe K, et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003;63:2286-2294.","DOI":"10.1046\/j.1523-1755.63.6s.2.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Coppo R, Camilla R, Amore A, et al. Oxidative stress in IgA nephropathy. Nephron Clin Pract 2010;116:c196-c199.","DOI":"10.1159\/000317199"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Say RE, Whittaker RG, Turnbull HE, et al. Mitochondrial disease in pregnancy: a systematic review. Obstet Med 2011;4:90-94.","DOI":"10.1258\/om.2011.110008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shigemi R, Fukuda M, Suzuki Y, et al. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation. Brain Dev 2011;33:518-520.","DOI":"10.1016\/j.braindev.2010.07.013"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u795e\u7d4c\u75c7\u72b6\u306b\u9577\u671f\u5148\u884c\u3057\u3066\u814e\u969c\u5bb3\u3092\u5448\u3057\u305fG13513A\u5909\u7570\u3092\u6709\u3059\u308bmitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes\uff08MELAS\uff09\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:06:35Z","timestamp":1621541195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/6\/53_446\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.446","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}